Relapse of acute lymphoblastic leukemia remains a major cause of death in patients following allogeneic hematopoietic stem cell transplantation. challenge, especially for adult ALL.1 For patients with ALL who relapse after allo-HSCT, the treatment options are limited as well as the clinical training course and prognostic elements affecting outcome never have been very well characterized.2,3… Continue reading Relapse of acute lymphoblastic leukemia remains a major cause of death